Literature DB >> 806395

Seasonal nephrotic syndrome. Description and immunological findings.

W G Reeves, J S Cameron, S G Johansson, C S Ogg, D K Peters, R O Weller.   

Abstract

Three cases are described showing a seasonal exacerbation of their nephrotic syndrome in association with an atopic trait and grass pollen allergy. The first patient has a history of four consecutive seasonal relapses each requiring steroid therapy. Following a course of desensitization injections he has now been free of relapse for 3 consecutive years. The second patient has also had a recurrent steroid-sensitive nephrotic syndrome often associated with the pollen season and allergic rhinitis. In this patient a course of cyclophosphamide has reduced his tendency to relapse. The third patient who has been on continuous prednisone therapy shows a seasonal increase in proteinuria. Serum changes in the first two patients include: a seasonal rise in total and grass pollen specific IgE; the continued presence of grass pollen specific IgG throughout the year but with a reduction during the pollen season in association with a more pronounced fall in the total IgG level; a depression in the C3 level in association with each major relapse; a mild rise in the I-K titre and a positive result in the Clq test for circulating complexes. A renal biopsy performed on the first patient when in relapse showed minor histological changes only and IgG, IgM, IgA, IgD, IgE, C3 and fibrinogen were undetectable by immunofluorescent examination. The probable mechanism for the development of proteinuria in these patients is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 806395     DOI: 10.1111/j.1365-2222.1975.tb01845.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN: 0009-9090


  21 in total

1.  Circannual variation in the onset and relapse of steroid-sensitive nephrotic syndrome.

Authors:  Shin-ichi Toyabe; Makiko Nakamizo; Makoto Uchiyama; Kouhei Akazawa
Journal:  Pediatr Nephrol       Date:  2005-02-18       Impact factor: 3.714

2.  Controlled trial of disodium cromoglycate in prevention of relapse of steroid-responsive nephrotic syndrome of childhood.

Authors:  R S Trompeter; P D Thomson; T M Barratt; J F Soothill
Journal:  Arch Dis Child       Date:  1978-05       Impact factor: 3.791

3.  Risk of idiopathic nephrotic syndrome among children with asthma: a nationwide, population-based cohort study.

Authors:  Chang-Ching Wei; Cheng-Li Lin; Te-Chun Shen; Yu-Fen Li
Journal:  Pediatr Res       Date:  2015-04-30       Impact factor: 3.756

Review 4.  The immune system in minimal change nephrotic syndrome.

Authors:  H W Schnaper
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

5.  Nephrotic syndrome of childhood: malaria therapy reconsidered.

Authors:  T M Barratt
Journal:  Arch Dis Child       Date:  1979-11       Impact factor: 3.791

6.  Th2 cells predominate in idiopathic steroid-sensitive nephrotic syndrome.

Authors:  Takahiro Kanai; Hirohiko Shiraishi; Takanori Yamagata; Takane Ito; Jun Odaka; Takashi Saito; Jun Aoyagi; Mariko Y Momoi
Journal:  Clin Exp Nephrol       Date:  2010-08-05       Impact factor: 2.801

7.  Two cases of the nephrotic syndrome with a reversible coagulation defect.

Authors:  M R Baker; J A Davies; G M Tate; M R Lee
Journal:  Postgrad Med J       Date:  1979-10       Impact factor: 2.401

8.  Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Authors:  Yuya Hashimura; Kandai Nozu; Hirokazu Kanegane; Toshio Miyawaki; Akira Hayakawa; Norishige Yoshikawa; Koichi Nakanishi; Minoru Takemoto; Kazumoto Iijima; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2009-02-03       Impact factor: 3.714

9.  Steroid-responsive nephrotic syndrome and allergy: immunological studies.

Authors:  S R Meadow; J K Sarsfield; D G Scott; S M Rajah
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791

10.  Increased risk of idiopathic nephrotic syndrome in children with atopic dermatitis.

Authors:  Chang-Ching Wei; Jeng-Dau Tsai; Cheng-Li Lin; Te-Chun Shen; Tsai-Chung Li; Chi-Jung Chung
Journal:  Pediatr Nephrol       Date:  2014-07-18       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.